| 2026-08-05 | 8-K | Form 8-K, Item 2.02 results |
| 2026-08-05 | 10-Q | Form 10-Q for the quarter ended Jun 27 |
| 2026-07-29 | Press release | Perrigo to Present at the Canaccord 46th Annual Growth Conference |
| 2026-07-06 | 8-K | Form 8-K, Item 5.02 |
| 2026-07-06 | 8-K | Form 8-K/A, Item 5.02 |
| 2026-06-30 | Press release | Perrigo Announces Appointment of Two New Independent Directors to Board |
| 2026-06-30 | 8-K | Form 8-K, Item 5.02 |
| 2026-06-08 | Press release | Perrigo Announces Leadership Transition |
| 2026-06-08 | 8-K | Form 8-K, Item 5.02 |
| 2026-05-26 | Press release | Perrigo to Present at the Oppenheimer 26th Annual Consumer Growth & E-Commerce Conference |
| 2026-05-06 | Deck | Q1 2026 Earnings Presentation |
| 2026-05-06 | Press release | Perrigo Reports First Quarter 2026 Financial Results From Continuing Operations |
| 2026-05-06 | 8-K | Form 8-K, Item 2.02 results |
| 2026-05-06 | 10-Q | Form 10-Q for the quarter ended Mar 28 |
| 2026-05-05 | 8-K | Form 8-K, Item 5.02 |
| 2026-04-30 | Press release | Perrigo Completes Divestiture of Dermacosmetics Business |
| 2026-04-30 | 8-K | Form 8-K, Item 2.01 |
| 2026-04-22 | Press release | Perrigo to Release First Quarter 2026 Financial Results on May 6, 2026 |
| 2026-04-22 | 8-K | Form 8-K, Item 2.02 results |
| 2026-03-23 | 8-K | Form 8-K, Item 1.01 |
| 2026-03-20 | Proxy | Definitive proxy statement |
| 2026-03-03 | Press release | Perrigo to Present at the UBS Global Consumer and Retail Conference |
| 2026-02-26 | Press release | Perrigo Reports Fourth Quarter and Fiscal Year 2025 Financial Results From Continuing Operations |
| 2026-02-26 | Deck | Q4 & FY2025 Earnings Presentation |
| 2026-02-26 | 8-K | Form 8-K, Item 2.02 results |
| 2026-02-26 | 10-K | Annual report on Form 10-K, FY25 |
| 2026-02-13 | Press release | Perrigo to Release Fourth Quarter and Fiscal Year 2025 Financial Results on February 26, 2026 |
| 2025-11-18 | Press release | Perrigo to Attend Morgan Stanley Global Consumer & Retail Conference |
| 2025-11-05 | Press release | Perrigo Reports Third Quarter 2025 Financial Results From Continuing Operations Amid Soft Market Consumption Trends, Achieved Q3 2025 Dollar, Unit and Volume Share(1) Gains in 5 of 7 Over-The-Counter ("OTC") Store Brand Categories and Dollar Share Gains in Key Brands Despite Marketplace Challenges, Delivered Meaningful YTD 2025 EPS Growth(2) with Gross and Operating Margin Expansion Initiates Strategic Review of Infant Formula Business (Announced in Separate Press Release); Continues Strategic Review of Oral Care Business; On-Track to Close Previously Announced Sale of Dermacosmetics Business in Q1'26 Updates Full Year 2025 Outlook Due Primarily to Infant Formula Industry Dynamics and Soft OTC Market Consumption Trends |
| 2025-11-05 | Deck | Q3 2025 Earnings Presentation |
| 2025-11-05 | Press release | Perrigo to Conduct Strategic Review of its Infant Formula Business |
| 2025-11-05 | 8-K | Form 8-K, Item 2.02 results |
| 2025-11-05 | 10-Q | Form 10-Q for the quarter ended Sep 27 |
| 2025-11-04 | Press release | Perrigo to Attend Jefferies Consumer Conference |
| 2025-10-22 | Press release | Perrigo to Release Third Quarter 2025 Financial Results on November 5, 2025 |
| 2025-08-20 | Press release | Perrigo to Attend Barclays 18th Annual Global Consumer Staples Conference |
| 2025-08-06 | Press release | Perrigo Reports Second Quarter 2025 Financial Results From Continuing Operations |
| 2025-08-06 | 8-K | Form 8-K, Item 2.02 results |
| 2025-08-06 | 10-Q | Form 10-Q for the quarter ended Jun 28 |
| 2025-07-29 | Press release | Perrigo to Present at the Canaccord Genuity 45th Annual Growth Conference |